Phase I/II clinical and pharmacokinetic study of ecubectedin in combination with irinotecan in patients with selected advanced solid tumors

被引：0
|
作者：
Torralvo, A. Gil [1 ]
Vieito, M. [2 ]
Martinez Perez, J. [1 ]
Pretelli, G. [2 ]
Martinez, V. [3 ]
Boggio, G. F. [4 ]
Fernandez, C. M. [4 ]
Hernandez, A. [4 ]
Cristoveanu, E. [4 ]
Belgrano, A. [4 ]
Kahatt, C. [4 ]
Fudio, S. [4 ]
Nieto, A. [4 ]
Redondo, A. [3 ]
机构：
[1] Hosp Univ Virgen Rocio, Oncol, Seville, Spain
[2] VHIO Vall dHebron Inst Oncol, Oncol, Barcelona, Spain
[3] Hosp Univ La Paz, Dept Oncol Med, Madrid, Spain
[4] PharmaMar SA, Clinical, Colmenar Viejo, Spain
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.708
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
641P
引用
收藏
页码：S508 / S508
页数：1
相关论文
共 50 条
  • [1] Phase I and pharmacokinetic study of docetaxel and irinotecan in patients with advanced solid tumors
    Couteau, C
    Risse, ML
    Ducreux, M
    Lefresne-Soulas, F
    Riva, A
    Lebecq, A
    Ruffié, P
    Rougier, P
    Lokiec, F
    Bruno, R
    Armand, JP
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) : 3545 - 3552
  • [2] Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, anti leucovorin in patients with advanced solid tumors
    Saltz, LB
    Kanowitz, J
    Kemeny, NE
    Schaaf, L
    Spriggs, D
    Staton, BA
    Berkery, R
    Steger, C
    Eng, M
    Dietz, A
    Locker, P
    Kelsen, DP
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (11) : 2959 - 2967
  • [3] Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation
    Allegrini, Giacomo
    Di Paolo, Antonello
    Cerri, Elisa
    Cupini, Samanta
    Amatori, Federica
    Masi, Gianluca
    Danesi, Romano
    Marcucci, Lorenzo
    Bocci, Guido
    Del Tacca, Mario
    Falcone, Alfredo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (05) : 585 - 593
  • [4] Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation
    Giacomo Allegrini
    Antonello Di Paolo
    Elisa Cerri
    Samanta Cupini
    Federica Amatori
    Gianluca Masi
    Romano Danesi
    Lorenzo Marcucci
    Guido Bocci
    Mario Del Tacca
    Alfredo Falcone
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 585 - 593
  • [5] Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: Preliminary evidence of clinical activity
    Adjei, AA
    Klein, CE
    Kastrissios, H
    Goldberg, RM
    Alberts, SR
    Pitot, HC
    Sloan, JA
    Reid, JM
    Hanson, LJ
    Atherton, P
    Rubin, J
    Erlichman, C
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (05) : 1116 - 1123
  • [6] Phase I and pharmacokinetic study of UCN-01 in combination with irinotecan in patients with solid tumors
    Jimeno, Antonio
    Rudek, Michelle A.
    Purcell, Thomas
    Laheru, Daniel A.
    Messersmith, Wells A.
    Dancey, Janet
    Carducci, Michael A.
    Baker, Sharyn D.
    Hidalgo, Manuel
    Donehower, Ross C.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (03) : 423 - 433
  • [7] Phase I and pharmacokinetic study of UCN-01 in combination with irinotecan in patients with solid tumors
    Antonio Jimeno
    Michelle A. Rudek
    Thomas Purcell
    Daniel A. Laheru
    Wells A. Messersmith
    Janet Dancey
    Michael A. Carducci
    Sharyn D. Baker
    Manuel Hidalgo
    Ross C. Donehower
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 423 - 433
  • [8] Phase I clinical and pharmacokinetic study of irofulven in combination with oxaliplatin in patients with advanced solid tumors.
    Alexandre, J
    Tchen, N
    Berthault-Cvitkovic, F
    Misset, JL
    Benettaib, B
    Kahatt, C
    Raymond, E
    Weems, G
    MacDonald, JR
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9057S - 9057S
  • [9] Dose-finding phase I clinical and pharmacokinetic study of orally administered irinotecan in patients with advanced solid tumors
    Kuppens, IELM
    Dansin, E
    Boot, H
    Feger, C
    Assadourian, S
    Bonneterre, ME
    Beijnen, JH
    Schellens, JHM
    Bonneterre, J
    CLINICAL CANCER RESEARCH, 2006, 12 (12) : 3774 - 3781
  • [10] A Phase I and pharmacokinetic study of selenomethionine in combination with a fixed dose of irinotecan in solid tumors
    Fakih, Marwan G.
    Pendyala, Lakshmi
    Brady, William
    Smith, Patrick F.
    Ross, Mary E.
    Creaven, Patrick J.
    Badmaev, Vladimir
    Prey, Joshua D.
    Rustum, Youcef M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (03) : 499 - 508
12345